UA97076C2 - Anti-inflammatory ointment based on sulfanilamide - Google Patents

Anti-inflammatory ointment based on sulfanilamide

Info

Publication number
UA97076C2
UA97076C2 UAA201105168A UAA201105168A UA97076C2 UA 97076 C2 UA97076 C2 UA 97076C2 UA A201105168 A UAA201105168 A UA A201105168A UA A201105168 A UAA201105168 A UA A201105168A UA 97076 C2 UA97076 C2 UA 97076C2
Authority
UA
Ukraine
Prior art keywords
sulfanilamide
inflammatory
ointment based
inflammatory ointment
ointment
Prior art date
Application number
UAA201105168A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Светлана Владимировна Бабий
Алена Владимировна Бабий
Александр Мефодиевич Черпак
Оксана Моисеевна Черпак
Original Assignee
Светлана Владимировна Бабий
Алена Владимировна Бабий
Александр Мефодиевич Черпак
Оксана Моисеевна Черпак
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Светлана Владимировна Бабий, Алена Владимировна Бабий, Александр Мефодиевич Черпак, Оксана Моисеевна Черпак filed Critical Светлана Владимировна Бабий
Priority to UAA201105168A priority Critical patent/UA97076C2/en
Publication of UA97076C2 publication Critical patent/UA97076C2/en
Priority to RU2012107600/15A priority patent/RU2493837C1/en

Links

Abstract

The invention relates to pharmacy and medicine, in particular to pharmaceutical compositions in ointment form having anti-inflammatory, analgetic, antimicrobial, wound-healthing and regenerative action. The ointment contains sulfanilamide, racemic camphor, Vaseline, rendered pork fat, butylhydroxyanisol and butylhydroxytoluene. Sulfanilamide is in micronized state.
UAA201105168A 2011-04-22 2011-04-22 Anti-inflammatory ointment based on sulfanilamide UA97076C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UAA201105168A UA97076C2 (en) 2011-04-22 2011-04-22 Anti-inflammatory ointment based on sulfanilamide
RU2012107600/15A RU2493837C1 (en) 2011-04-22 2012-02-28 Anti-inflammatory ointment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201105168A UA97076C2 (en) 2011-04-22 2011-04-22 Anti-inflammatory ointment based on sulfanilamide

Publications (1)

Publication Number Publication Date
UA97076C2 true UA97076C2 (en) 2011-12-26

Family

ID=49164508

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201105168A UA97076C2 (en) 2011-04-22 2011-04-22 Anti-inflammatory ointment based on sulfanilamide

Country Status (2)

Country Link
RU (1) RU2493837C1 (en)
UA (1) UA97076C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009789B (en) * 2019-03-18 2020-08-03 Ελενη Δημητριου Πατσιανιδη Ointment for burns

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83402C2 (en) * 2006-07-06 2008-07-10 Светлана Владимировна Бабий Anti-inflammatory analgesic ointment
RU2401104C2 (en) * 2008-12-04 2010-10-10 Закрытое акционерное общество "Биологические исследования и системы" Topical and external tilorone pharmaceutical composition for treatment of purulent-destructive mucosal and skin diseases, systemic diseases in immunodeficiency states

Also Published As

Publication number Publication date
RU2493837C1 (en) 2013-09-27
RU2012107600A (en) 2013-09-10

Similar Documents

Publication Publication Date Title
MX2015008628A (en) Boronic acid derivatives and therapeutic uses thereof.
EA201690102A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
IN2014DN09434A (en)
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
BR112015000229A2 (en) stable aqueous formulations of etanercept
MX348823B (en) Stable formulations of linaclotide.
BR112013008601A8 (en) CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS
BR112015011430A2 (en) composition for immediate and prolonged release
BRPI0806713A8 (en) STABLE THIACUMICIN COMPOSITIONS
MX2013003635A (en) N-heteroaryl compounds.
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
EP2682101A3 (en) Inhalation Compositions Comprising Glucose Anhydrous
UA112420C2 (en) APOPTOSIS INHIBITORS AND THEIR APPLICATIONS
WO2015001163A3 (en) Lipid nanoparticles for healing wounds
IN2015DN01328A (en)
MX364652B (en) Pharmaceutical formulation comprising ciclesonide.
WO2015002755A3 (en) Compounds for the treatment of malaria
EP2682129A3 (en) Compositions Comprising Muscarinic Receptor Antagonist and Glucose Anhydrous
EP2611799A4 (en) Pharmaceutical compositions of linezolid
MX2013013079A (en) Compositions comprising antibacterial agent and tazobactam.